8F6A
Thermoplasma acidophilum 20S proteasome - wild type
8F6A の概要
| エントリーDOI | 10.2210/pdb8f6a/pdb |
| EMDBエントリー | 28878 |
| 分子名称 | Proteasome subunit beta, Proteasome subunit alpha (2 entities in total) |
| 機能のキーワード | protease, threonine protease, endopeptidase activity, hydrolase |
| 由来する生物種 | Thermoplasma acidophilum 詳細 |
| タンパク質・核酸の鎖数 | 28 |
| 化学式量合計 | 685989.61 |
| 構造登録者 | |
| 主引用文献 | Chuah, J.J.Y.,Rexroad, M.S.,Smith, D.M. High resolution structures define divergent and convergent mechanisms of archaeal proteasome activation. Commun Biol, 6:733-733, 2023 Cited by PubMed Abstract: Considering the link between neurodegenerative diseases and impaired proteasome function, and the neuro-protective impact of enhanced proteasome activity in animal models, it's crucial to understand proteasome activation mechanisms. A hydrophobic-tyrosine-any residue (HbYX) motif on the C-termini of proteasome-activating complexes independently triggers gate-opening of the 20S core particle for protein degradation; however, the causal allosteric mechanism remains unclear. Our study employs a structurally irreducible dipeptide HbYX mimetic to investigate the allosteric mechanism of gate-opening in the archaeal proteasome. High-resolution cryo-EM structures pinpoint vital residues and conformational changes in the proteasome α-subunit implicated in HbYX-dependent activation. Using point mutations, we simulated the HbYX-bound state, providing support for our mechanistic model. We discerned four main mechanistic elements triggering gate-opening: 1) back-loop rearrangement adjacent to K66, 2) intra- and inter- α subunit conformational changes, 3) occupancy of the hydrophobic pocket, and 4) a highly conserved isoleucine-threonine pair in the 20S channel stabilizing the open and closed states, termed the "IT switch." Comparison of different complexes unveiled convergent and divergent mechanism of 20S gate-opening among HbYX-dependent and independent activators. This study delivers a detailed molecular model for HbYX-dependent 20S gate-opening, enabling the development of small molecule proteasome activators that hold promise to treat neurodegenerative diseases. PubMed: 37454196DOI: 10.1038/s42003-023-05123-3 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (2.06 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






